Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.900
+0.080 (2.84%)
Jun 23, 2026, 4:00 PM EDT - Market closed
Cellectis Market Cap
Cellectis has a market cap or net worth of $207.27 million as of June 23, 2026. Its market cap has increased by 103.40% in one year.
Market Cap
207.27M
Enterprise Value
105.49M
1-Year Change
103.40%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $207.27M, a decrease of -84.58%. That is a compound annual growth rate of -15.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 207.27M | -40.80% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 210.13M |
| Arcturus Therapeutics Holdings | 205.50M |
| Karyopharm Therapeutics | 203.97M |
| Immunic | 200.92M |
| Korro Bio | 200.47M |
| Nkarta | 199.61M |
| ProQR Therapeutics | 198.08M |
| Alector | 197.62M |